The first twice-daily injectable HIV prevention drug based on lenacapavir has received CHMP recommendation for authorization, promising an effective and affordable solution.
Cristina Petrache
Health
Foto pexels.com
Always see our news on Google
Lenacapavir is the first twice-daily injectable drug for the prevention of HIV infection, with 99.9% efficacy in clinical trials. Recommended by the CHMP, this treatment simplifies prevention by eliminating the need for daily tablets. In Romania, where the cost of HIV treatment is high, the new PrEP could reduce costs and improve access for vulnerable people. Approved at European level, this drug represents a significant opportunity to transform HIV prevention into public health policy.
Sources
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o şansă uriaşă pentru prevenţia HIV în România
Europa se apropie de aprobarea primului tratament PrEP injectabil cu administrare la 6 luni - o șansă uriașă pentru prevenția HIV în România
Omenirea, mai aproape ca niciodată de a opri virusul HIV. Europa a autorizat tratamentul revoluționar
E.U. regulator approves injectable HIV drug that experts say could help stop transmission
EU regulator approves injectable HIV drug that experts say could help stop transmission
Latest News
10:09
The latest report on the floods in Nepal and Tibet: At least 470 dead and over 1,000 missing / Rescue operations have been temporarily suspended due to the risks of new floods.
09:42
Nae Ungureanu has died, the legend of Craiova Maxima. The former international was 69 years old.
09:31
Large technology companies warn of a wave of cyberattacks amplified by AI and call for strengthening cybersecurity.
09:05
The stockpiles of US Patriot missiles in Europe are at a "much more than critical" level due to the war with Iran. What are the implications for NATO?
08:55
The violent storms in the south of the country caused destruction in Călărași County, where trees were uprooted, and a waterspout formed on the coast.
See more news
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
